Professor timothy caulfield



Download 477.43 Kb.
Page1/6
Date03.03.2018
Size477.43 Kb.
#41838
  1   2   3   4   5   6
PROFESSOR TIMOTHY CAULFIELD

Curriculum Vitae
Faculty of Law

4th Floor Law Centre, University of Alberta

Edmonton, AB T6G 2H5
Phone (W):(780) 492-8358
Phone (H):(780) 433-6778
E-mail: caulfield@ualberta.ca



1. EMPLOYMENT 2

2. CHAIRS, FELLOWSHIPS, VISITING PROFESSORSHIPS AND DIRECTORSHIPS 2

3. APPOINTMENTS AND AWARDS 3

4. EDUCATION AND PROFESSIONAL QUALIFICATIONS 4

5. PUBLISHED WORKS 4

Books and Edited Collections 4

Academic Articles 6

Book Chapters 27

Selected Articles and Work with the Popular Press and Media 31

Book Reviews, Introductions, and Commentaries 37

Selected National and International Policy Reports/Commissioned Papers and Reports 39

6. SELECTED CONFERENCE PRESENTATIONS AND INVITED LECTURES 42

7. PROFESSIONAL SERVICE 85

Conferences and Workshops Organized 85

Editorial Boards (current and recent) 87

Select Memberships, Committees, and Associations 87

8. TEACHING AND ACADEMIC SUPERVISION 91

Courses Taught 91

Trainees of the Health Law Institute Supervised and Current Positions 91

Law Graduate Students Supervised 92

Other Faculty Supervision 93

Student Research Assistants Supervised 93

9. PEER REVIEWED GRANTS 94

1. EMPLOYMENT



Professor

Faculty of Law and School of Public Health, University of Alberta, 2004-


TV Host and Co-Producer

“A User’s Guide to Cheating Death,” Peacock Alley Entertainment, 2016-


Associate Professor

Faculty of Law and Faculty of Medicine and Dentistry, University of Alberta, 1999-2004


Assistant Professor (Trust)

Faculty of Law, University of Alberta, 1996-1999


Lawyer

Bryan & Company, Barristers and Solicitors, Edmonton, Alberta, 1991-1992


Student-at-Law

Bryan & Company, Barristers and Solicitors, Edmonton, Alberta, 1990-1991


Legal Researcher

Health Law Institute, University of Alberta, 1988-1990


2. CHAIRS, FELLOWSHIPS, VISITING PROFESSORSHIPS AND DIRECTORSHIPS



Tier I Canada Research Chair in Health Law and Policy

University of Alberta, 2016 –


Research Director

Health Law Institute, Faculty of Law, University of Alberta, 1993-2011, 2012-present


Research Director

Health Law and Science Policy Group (HeaLS), Faculty of Law, University of Alberta, 2011-2012


Tier I Canada Research Chair in Health Law and Policy

University of Alberta, 2009-present



Tier II Canada Research Chair in Health Law and Policy
University of Alberta, 2002-2009

Director of Research
Commission of Inquiry on Hormone Receptor Testing, Government of Newfoundland and Labrador, 2007-2008

Visiting Professor

University of Basel, Switzerland, 2014


Erasmus Mundus Visiting Scholar

University of Leuven, 2012



Visiting Scholar
SCRIPTS, University of Edinburgh, Faculty of Law, 2011

Visiting Professor
Health Law and Policy Institute, University of Houston, 2005

Visiting Scholar
Hastings Center, Garrison, New York, 2000

Visiting Fellowship
Stanford University, Program in Genomics, Ethics, and Society
Palo Alto, California, 1997

Visiting Scholar

Stanford University, Law 1997


3. APPOINTMENTS AND AWARDS



2017 Best Column, Canadian Digital Publishing Awards
2016 Distinguished Academic Award, The Confederation of Alberta Faculty Associations (CAFA)

Alberta’s 50 Most Influential People 2016, Alberta Venture Magazine

Canadian Science Writers Association, 2015 Best Book winner – Is Gwyneth Paltrow Wrong About Everything?
Associate, Mason Institute for Medicine, Life Sciences and the Law, University of Edinburgh 2016
Fellow, Trudeau Foundation, 2013 -
Fellow, Royal Society of Canada, 2007
Fellow, Canadian Academy of Health Sciences, 2006

Alberta’s 50 Most Influential People 2014, Alberta Venture Magazine

Alberta Readers’ Choice Award 2013 Top Ten, for “The Cure for Everything” (Penguin)

National Magazine Awards, Honorable Mention, Best Health and Medicine Article, 2012

Till and McCulloch Award for Exceptional Contributions to Global Stem Cell Research
Stem Cell Network, 2010

Media Relations Award
University of Alberta, Senate Community Recognition, 2004

Alumni Horizon Award for early career recognition of outstanding achievements
University of Alberta Alumni Association, 2002

Health Research Scholarship
Alberta Heritage Foundation for Medical Research, 2001

Martha Cook Piper Research Prize for original research and outstanding promise as a researcher
University of Alberta, 2000

Medical Research Population Health Investigator Award

Alberta Heritage Foundation, 1996, renewed 1999-


4. EDUCATION AND PROFESSIONAL QUALIFICATIONS

LL.M., Faculty of Law, Dalhousie University, 1993

(Thesis: “The Last Straw: The Impact of Cost Containment in Health Care on Medical Malpractice Law” 204 pp.)

Admitted to the Law Society of Alberta, 1991

LL.B., Faculty of Law, University of Alberta, 1990

Bachelor of Science, University of Alberta, 1987


5. PUBLISHED WORKS


Books and Edited Collections

Timothy Caulfield, The Vaccination Picture (Penguin Canada, 2017).


Timothy Caulfield, Is Gwyneth Paltrow Wrong About Everything: When Celebrity Culture and Science Clash (Penguin, 2015); and published in the US as Is Gwyneth Paltrow Wrong About Everything?: How the Famous Sell Us Elixirs of Health, Beauty & Happiness (Beacon Press, 2015).
Nola Ries, Tracey Bailey and Timothy Caulfield, ed., Public Health Law and Policy in Canada, 3rd ed. (LexisNexis Canada, 2013) 731pp.

Timothy Caulfield, ed., Using and Abusing Evidence in Science and Health Policy: Article Collection (BioMed Central, 2013) (http://www.biomedcentral.com/series/EvidenceUseAbuse).

Timothy Caulfield, The Cure for Everything: Untangling the Twisted Messages About Health, Fitness and Happiness (Penguin, 2012) 320 pp.

Timothy Caulfield, Guest Editor, Special Issues: Neuroscience: Emerging Legal and Policy Issues, (2012) 35 International Journal of Law and Psychiatry.

Co-editor with Sean Caulfield and Curtis Gillespie, Perceptions of Promise: Biotechnology, Society and Art (Department of Art and Design and University of Washington Press, 2011) 93 pp. (article contribution “Monsters in the Media” pp. 82-85).

Jocelyn Downie, Timothy Caulfield, and Colleen Flood, eds., Canadian Health Law and Policy, 4th ed. (LexisNexis Canada, 2011) 670 pp.

Sean Caulfield and Timothy Caulfield, eds., Imagining Science: Art, Science and Social Change (The University of Alberta Press, 2008) 106 pp.

Tracey Bailey, Timothy Caulfield, and Nola Ries, Public Health Law and Policy in Canada, 2nd ed. (LexisNexis Canada, 2008) pp. 597. (Chapter contribution: “Genetics and Public Health: Legal, Ethical and Policy Challenges” pp. 559-581).

Jocelyn Downie, Timothy Caulfield, and Colleen Flood, eds., Canadian Health Law and Policy, 3rd ed. (Butterworths (Canada) Ltd, 2007) 603 pp.

Tracey Bailey, Timothy Caulfield, and Nola Ries, eds., Public Health Law and Policy (Toronto: Butterworths, 2005) 365 pp. (Chapter contribution: “Genetics and Public Health: Legal, Ethical and Policy Challenges” pp. 477-495).

Jocelyn Downie, Timothy Caulfield, and Colleen Flood, eds., Canadian Health Law and Policy, 2nd ed (Toronto: Butterworths, 2002) 601 pp.

Barbara von Tigerstrom and Timothy Caulfield, eds., Meeting the Challenge: Health Care Reform and the Law (University of Alberta Press, 2002) 288 pp.

Timothy Caulfield and Bryn Williams-Jones, eds., The Commercialization of Genetic Research: Ethical, Legal and Policy Issues (New York: Kluwer Academic/Plenum Publishing, 1999) 200 pp.

Jocelyn Downie and Timothy Caulfield, eds., Canadian Health Law and Policy (Toronto: Butterworths, 1999) 438 pp.

Bartha Maria Knoppers, Timothy Caulfield, and Douglas Kinsella, eds., Legal Rights and Human Genetic Material (Toronto: Emond Montgomery, 1996) 180 pp.

Academic Articles

Christen Rachul, John Rasko, and Timothy Caulfield, “Implicit hype? Representations of platelet rich plasma in the news media” (2017) 12(8) PLoS ONE 1-9. (PR)
Timothy Caulfield and Blake Murdoch, “Genes, cells, and biobanks: Yes, there's still a consent problem” (2017) 15 (7) PLOS Biology 1-9. (PR)
Doug Sipp, Timothy Caulfield, Jane Kaye, et al., “Marketing of unproven stem cell–based interventions: A call to action” (2017) 9 Science Translational Medicine 1-5. (PR)
Timothy Caulfield, Alessandro Marcon and Blake Murdoch, “Injecting doubt: responding to the naturopathic anti-vaccination rhetoric” (2017) Journal of Law and the Biosciences 1-21. (PR)
Timothy Caulfield, “The direct-to-consumer genetic testing fog” (25 May 2017) Policy Options.
Timothy Caulfield and Maeghan Toews, “Rare Diseases and Resource Allocation Policy: The Role of Canadian Legal Norms” (2017) 49 UBC Law Review 789-815. (PR)
Alessandro R. Marcon and Timothy Caulfield, “Commenting on chiropractic: A YouTube analysis” (2017) 4 Cogent Medicine 1-22. (PR)

Timothy Caulfield, “Tom Brady and Vagina Eggs” (2 February 2017) Policy Options.


Bartha Knoppers, Rosario Isasi, Timothy Caulfield, et al, “Human gene editing: revisiting Canadian policy (2017) 3 Regenerative Medicine. (PR)
Blake Murdoch, Vardit Ravitsky, et al., and Timothy Caulfield, “Non-Invasive Prenatal Testing and the Unveiling of an Impaired Translation Process” (2017) 39 Journal of Obstetrics and Gynaecology Canada 10-17. (PR)
Timothy Caulfield, “In 2017, Let’s Take Back Science!” (11 January 2017) Policy Options.
Li Du, Blake Murdoch, Carina Chiu, JD and Timothy Caulfield, “Compelled Disclosure of Confidential Information in Patient Safety Research” (2017) Journal of Patient Safety. (PR)

Steven Hoffman, et al., Timothy Caulfield, “Celebrities’ impact on health-related knowledge, attitudes, behaviors, and status outcomes: protocol for a systematic review, meta-analysis, and meta-regression analysis” (2017) 6 Systematic Reviews. (PR)


Maeghan Toews and Timothy Caulfield, “Evaluating the “family veto” of consent for organ donation” (2016) 188 CMAJ 17-18. (PR)

Blake Murdoch, Stuart Carr, Timothy Caulfield, “Selling falsehoods? A cross- sectional study of Canadian naturopathy, homeopathy, chiropractic and acupuncture clinic website claims relating to allergy and asthma” (2016) 6 BMJ Open e014028. (PR)


Timothy Caulfield: “Vaccines work and “natural” alternatives are bunk!” (25 October 2016) Policy Options.

Timothy Caulfield, “Ethics Hype” (2016) 46 Hastings Center Report 13-16. (PR)


Timothy Caulfield and Amy Zarzeczny, “Curbing transplant tourism: Canadian physicians and the law” (2016) 188 CMAJ 935-936. (PR)

Blake Murdoch and Timothy Caulfield, “Doing Research with Vulnerable Populations: The Case of Intravenous Drug Users” (2016) 5 Bioéthique 1-11. (PR)



Alessandro R Marcon, Philip Klostermann, Timothy Caulfield, “Chiropractic and Spinal Manipulation Therapy on Twitter” (2016) 2 JMIR Public Health and Surveillance 1-11. (PR)
Timothy Caulfield, “Olympic Debunk” (August 5, 2016) Policy Options.
Timothy Caulfield, “Science, Celebrities and Public Engagement” (Summer 2016) Issues in Science and Technology 24-26.
Timothy Caulfield, Douglas Sipp, Charles Murry, George Daley and Jonathan Kimmelman, “Confronting Stem Cell Hype” (2016) 351 Science 776-777. (PR)
Jonathan Kimmelman, Insoo Hyun, Nissim Benvenisty, Timothy Caulfield, Helen E. Heslop, Charles E. Murry, Douglas Sipp, Jeremy Sugarman, Lorenz Studer, George Q Daley, “Scientists must set global standards” (2016) 531 Nature 311-313. (PR)
Jonathan Kimmelman, Insoo Hyun, Nissim Benvenisty, Timothy Caulfield, Helen E. Heslop, Charles E. Murry, Douglas Sipp, Jeremy Sugarman, Lorenz Studer, George Q. Daley, “New ISSCR guidelines: clinical translation of stem cell research” (2016) The Lancet. (PR)
George Daley, Insoo Hyun, Jane Apperley, Roger Barker, Nissim Benvenisky, Anneliem Bredenoord, Christopher K. Breuer, Timothy Caulfield, et al., “Setting the Global Standard for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines” (2016) 6 Stem Cell Reports 1-11. (PR)
Timothy Caulfield, “From Kim Kardashian to Dr. Oz: The Future Relevance of Popular Culture to Our Health and Health Policy” (2016) 47 Ottawa Law Review 369-389. (PR)
Timothy Caulfield, “Time to stop legitimizing pseudoscientific health remedies” (April 2016) Policy Options.
Christen Rachul, Maeghan Toews, Timothy Caulfield , “Controversies with Kalydeco: newspaper coverage in Canada and the United States of the cystic fibrosis “wonder drug”, (2016) 15 Journal of Cystic Fibrosis 624-629. (PR)
Timothy Caulfield, “Talking about obesity:
An increasingly delicate task” (April 2016) Policy Options
Li Du, Christen Rachul, Zhaochen Guo, Timothy Caulfield, “Gordie Howe’s ‘Miraculous Treatment’: Case Study of Twitter Users’ Reactions to a Sport Celebrity’s Stem Cell Treatment” (2016) 2 JMIR Public Health Surveillance e8. (PR)
Timothy Caulfield, “The world is flat! Bring on reiki, homeopathy and all that other bunk!” (10 February 2016) Policy Options.
Charles Auffray, Timothy Caulfield, Julian L. Griffin, et al., “From genomic medicine to precision medicine: highlights of 2015” (2016) 8 Genome Medicine 1-6. (PR)
Timothy Caulfield, Wilma Duijst, Mike Bos, et al., “Trafficking in Human Beings for the Purpose of Organ Removal and the Ethical and Legal Obligations of Healthcare Providers” (2016) 2 Transplantation Direct e60. (PR)
Timothy Caulfield, Pascal Borry, Maeghan Toews, Bernice Elger, Hank Greely and Amy McGuire, “Marginally scientific? Genetic testing of children and adolescents for lifestyle and health promotion” (2016) Journal of Law and the Biosciences 1–18. (PR)
Kalina Kamenova, Vardit Ravitsky, Spencer McMullin, and Timothy Caulfield, “Media Portrayal of Non-Invasive Prenatal Testing: A Missing Ethical Dimension” (2016) 15 The Journal of Science Communication 1-19. (PR)
Timothy Caulfield, et al., “Trafficking in Human Beings for the Purpose of Organ Removal and the Ethical and Legal Obligations of Healthcare Providers” (2016) 2 Transplantation Direct e60. (PR)

Timothy Caulfield, “Genetic Discrimination” (7 December 2015) Policy Options.


Timothy Caulfield, “Food Choices, the Prius, Celebrities and My Shaved Legs” (23 October 2015) Policy Options.
Timothy Caulfield and Ubaka Ogbogu, “The commercialization of university-based research: Balancing risks and benefits” (2015) 16 BMC Medical Ethics 1-7. (PR)
Christen Rachul and Timothy Caulfield, “The media and access issues: content analysis of Canadian newspaper coverage of health policy decisions” (2015) Orphanet Journal of Rare Diseases 10:102. (PR)
Li Du, Kalina Kamenova and Timothy Caulfield, “The gene patent controversy on Twitter: a case study of Twitter users’ responses to the CHEO lawsuit against Long QT gene patents” (2015) BMC Medical Ethics 16:55. (PR)
Jeremy Snyder, Krystyna Adams, Y.Y. Chen, Daniel Birch, Timothy Caulfield, et al.

“Navigating physicians’ ethical and legal duties to patients seeking unproven interventions abroad” (2015) 61 Canadian Family Physician July 584-586. (PR)


Timothy Caulfield, “Let’s Take Sleep Seriously” (July 2015) Policy Options.
Christen Rachul & Timothy Caulfield, “Gordie Howe’s Stem Cell ‘Miracle’: A Qualitative Analysis of News Coverage and Readers’ Comments in Newspapers and Sports Websites” (2015) 11(5) Stem Cells Reviews and Reports 667-75. (PR)
Timothy Caulfield, “Obesity Genes, Personalized Medicine, and Public Health Policy” (2015) 4 Current Obesity Reports 319-323. (PR)
Timothy Caulfield, “Be mindful, but not mindless” (May/June 2015) Policy Options 4-5.
Christen M. Rachul, Ivona Percec and Timothy Caulfield, “The Fountain of Stem Cell-Based Youth? Online Portrayals of Anti-Aging Stem Cell Technologies” (2015) 35 (6) Aesthetic Surgery Journal, 2015, 730-736. (PR)
Timothy Caulfield, “Homeopathy and the ethics of researching magic” (February 2015) Policy Options.
Timothy Caulfield, “The Obesity Gene and the (Misplaced) Search for a Personalized Approach to Our Weight Gain Problems” (2015) 5 Wake Forest Journal of Law and Policy 125-145. (PR)
Kalina Kamenova and Timothy Caulfield, “Stem cell hype:Media portrayal of therapy translation” (2015) 7 (278) Science Translational Medicine 1-4. (PR)
Timothy Caulfield, “Be mindful, but not mindless” (May/June 2015) Policy Options 4-5.
Jacob Shelley, Marianne Clark, Timothy Caulfield, “The face of chiropractic: evidence-based?” (2015) 20 Focus on Alternative and Complementary Therapies 13-22. (PR)
Ubaka Ogbogu and Timothy Caulfield, “’Science Powers Commerce’: Language, Justification and Perceptions of the Drive to Commercialize Canadian Research” (2015) 1 Canadian Journal of Comparative and Contemporary Law 137-158. (PR)
Timothy Caulfield, “Homeopathy and the ethics of researching magic” (February 2015) Policy Options.
Timothy Caulfield, “Athletes and unproven stem cell therapies” (January 2015) Policy Options.
Timothy Caulfield, Kalina Kamenova, Ubaka Ogbogu, et al., “Research ethics and stem cells” (2015) 16 EMBO Reports 2-6.
Timothy Caulfield, Marianne I Clark, James P McCormack, Christen Rachul, Catherine J Field, “Representations of the health value of vitamin D supplementation in newspapers: media content analysis” (2014) 4 BMJ Open e006395. (PR)
Timothy Caulfield and Nola M. Ries, “Obesity Policy: The Way Forward” (2014) 22 Health Law Review 28-32.
Timothy Caulfield, “Organic ideologies” (November 2014) Policy Options.
Maeghan Toews and Timothy Caulfield “Physician Liability and Non-Invasive Prenatal Testing” (2014) 36:10 Journal of Obstetrics and Gynaecology Canada (907-914). (PR)
Timothy Caulfield “Fitness Fantasies” (2014) Policy Options 6-7.
Timothy Caulfield and Amy Zarzeczny, “Defining medical necessity in an age of personalised medicine: A view from Canada” (2014) 36:9 Bioessays 813-817. (PR)
Zubin Master, Kelsey Robertson, Daniel Frederick, Christen Rachul and Timothy Caulfield “Stem Cell Tourism and Public Education: The Missing Elements” (2014) Cell Stem Cell 15:3, 267-270. (PR)

Amy Zarzeczny, Timothy Caulfield, Ubaka Ogbogu, Peter Bell, Valorie A Crooks, Kalina Kamenova, Zubin Master, Christen Rachul, Jeremy Snyder, Maeghan Toews, and Sonja Zoeller “Professional Regulation: A Potentially Valuable Tool in Responding to “Stem Cell Tourism”” (2014) 3 (3) Stem Cell Reports, 379-384 1-6. (PR)

Ubaka Ogbogu, Maeghan Toews, Adam Ollenberger, Pascal Borry, Helene Nobile, Manuela Bergmann, Timothy Caulfield “Newspaper Coverage of Biobanks” PeerJ (2014) 2:e500; DOI 10.7717/peerj.500. (PR)

Kalina Kamenova, Amir Reshef, Timothy Caulfield “Representations of Stem Cell Clinics on Twitter” (2014) 10 (6) Stem Cell Reviews and Reports, 753-760. (PR)

Zubin Master, Lisa Campo-Engelstein and Timothy Caulfield, “Scientists’ perspectives on consent in the context of biobanking research” (2014) European Journal of Human Genetics (2014), 1–6. (PR)



Timothy Caulfield “It’s not all in the genes” (2014) Policy Options 56-57.

Timothy Caulfield, Erin Nelson, Brice Goldfeldt, and Scott Klarenback, “Incentives and organ donation: What's (really) legal in Canada?” (2014) Canadian Journal of Kidney Health and Disease, 1:7. (PR)

Yasuko Takezawa, Kazuto Kato, Hiroki Oota, Timothy Caulfield, et al., “Human genetic research, race, ethnicity and the labeling of populations: recommendations based on an interdisciplinary workshop in Japan” (2014) 15:33 BMC Medical Ethics. (PR)



Timothy Caulfield, Sarah Burningham, Yann Joly, et al, “A review of the key issues associated with the commercialization of biobanks” (2014) Journal of Law and the Biosciences, 94–110. (PR)
Timothy Caulfield, Pascal Borry and Herbert Gottweis, “Industry Involvement in Publicly Funded Biobanks” (2014) Nature Reviews Genetics, 15, 220. (PR)
John S. Gill, Scott Klarenbach, Lianne Barnieh, Timothy Caulfield, Greg Knoll, Adeera Levin and Edward H. Cole, “Financial Incentives to Increase Canadian Organ Donation: Quick Fix or Fallacy?” (2014) 63 Am J Kidney Dis 133-40. (PR)
Timothy Caulfield “Integrating nonsense?” (May 2014) Policy Options 6-8.
Timothy Caulfield “Easy test. Tough answers” (March 2014) Policy Options 8-9.
Ubaka Ogbogu, Sarah Burningham, and Timothy Caulfield, “The Right to Control and Access Genetic Research Information: Does McInerney Offer a Way Out of the Consent/Withdrawal Conundrum? University of British Columbia Law Review (2014) Vol 47:1, 275-292. (PR)
Ubaka Ogbogu et al, and Timothy Caulfield, “Policy recommendations for addressing privacy challenges associated with cell-based research and interventions” (2014) 15:7 BMC Medical Ethics. (PR)
Timothy Caulfield, “To a healthy and gimmick-free 2014!” (January 2014) Policy Options 8-9.
Kalina Kamenova, Amir Reshef & Timothy Caulfield, “Angelina Jolie’s faulty gene: newspaper coverage of a celebrity’s preventive bilateral mastectomy in Canada, the United States, and the United Kingdom” (2013) Genetics in Medicine. (PR)
Sarah Burningham, Adam Ollenberger, and Timothy Caulfield, “Commercialization and Stem Cell Research: A Review of Emerging Issues” (2013) 22 Stem Cells and Development 80-84. (PR)
Timothy Caulfield, Jim Evans, Amy McGuire, Chris McCabe, Tania Bubela, et al. “Reflections on the Cost of ‘‘Low- Cost’’ Whole Genome Sequencing: Framing the Health Policy Debate” (2013) PLoS Biology 11(11): e1001699. (PR)
Timothy Caulfield and Pascal Borry, “Direct-to-Consumer Genetic Testing – Where Should we Focus the Policy Debate” (2013) 9 Medical Journal of Australian 499-500. (PR)
Timothy Caulfield and Amy L. McGuire, “Policy Uncertainty, Sequencing and Cell Lines” (2013) 3 Genes/Genomes/Genetic 1205-1207. (PR)
Timothy Caulfield, Subhashini Chandrasekharan, Yann Joly and Robert Cook-Deegan, “Harm, Hype and Evidence: ELSI Research and Policy Guidance” (2013) 5 Genome Medicine 1-6. (PR)
Timothy Caulfield, “Time to encourage organ donation” (November 2013) Policy Options 6-7.
Sarah Burningham, Wayne Renke and Timothy Caulfield, “Is Patient Safety Research Protected From Disclosure” (2013) 20 Health Law Journal 47-72.
Timothy Caulfield, “The Paradoxes of Pop Science” (September/October 2013) Policy Options 12-13.
Zubin Master, Amy Zarzeczny, Christen Rachul and Timothy Caulfield, “What’s Missing: Discussing Stem Cell Translational Research in Educational Information on Stem Cell ‘Tourism’” (2013) 4 Journal of Law, Medicine and Ethics 254-268. (PR)
Sarah Burningham, Christen Rachul and Timothy Caulfield, “Informed Consent and Patient Comprehension: The Law and the Evidence” (2013) 7 McGill Journal of Law and Health 123-128. (PR)
Charles Auffray, Timothy Caulfield, Muin Khoury, et al., “2012 Highlights in Translational ‘Omics” (2013) 5 Genome Medicine 1-5. (PR)
Ubaka Ogbogu, Christen Rachul and Timothy Caulfield, “Reassessing Direct-to-Consumer Portrayals of Unproven Stem Cell Therapies: Is it getting Better?” (2013) 8 Regenerative Medicine 361-369. (PR)
Zubin Master, Jaime Claudio, Christen Rachul, Jean Wang, Mark Minden and Timothy Caulfield, “Cancer Patient Perceptions on the Ethical and Legal Issues Related to Biobanking” (2013) 6 BMC Medical Genomics 1-10. (PR)
Timothy Caulfield, Ubaka Ogbogu and Gerald Robertson, “The Law, Unproven CAM, and the Referral Challenge” (2013) 18(1) Focus on Alternative and Complementary Medicine 1-7. (PR)
Kim Raine, Tim Lobstein, Jane Landon, Monigue Kent, Suzie Pellerin, Timothy Caulfield, et al., “Restricting Marketing to Children: Consensus on Policy Interventions to Address Obesity” (2013) Journal of Public Health Policy 1-15. (PR)
Christen Rachul, Heather Boon and Timothy Caulfield, “Newspaper Portrayals of Spinal Manipulation Therapy: Canada, United States and the United Kingdon” (2013) 12(1) Journal of Science Communication 1-11. (PR)
Erica Haimes, Loane Skene, Angela Ballantyne, Timothy Caulfield, et al., “Position Statement on the Provision and Procurement of Human Eggs for Stem Cell Research” (2013) 12 Cell Stem Cell 285-291. (PR)
Ubaka Ogbogu, Li Du, Christen Rachul, Lisa Belanger and Timothy Caulfield, “Chinese Newspaper Coverage of (Unproven) Stem Cell Therapies and their Providers” (2013) Stem Cell Reviews and Reports 1-8. (PR)
Lianne Barnieh, Scott Klarenbach, John S. Gill, Timothy Caulfield, and Braden Manns,

“Attitudes Toward Strategies to Increase Organ Donation: Views of the General Public and Health Professionals” (2012) 7 Clinical Journal of the American Society of Nephrology. (PR)


Timothy Caulfield, “Athletes’ Use of Unproven Stem Cell Therapies: Adding to Inappropriate Media Hype?” (2012) Molecular Therapy 1656-1658. (PR)
Zubin Master, Erin Nelson, Blake Murdoch and Timothy Caulfield, “Biobanks, Consent and Claims of Consensus” (2012) 9 Nature Methods 885-888. (PR)
Timothy Caulfield, Christen Rachul and Amy Zarzeczny, “The Evolution of Policy Issues in Stem Cell Research: An International Survey” (August 2012) Stem Cell Reviews and Reports. (PR)
Timothy Caulfield, Christen Rachul and Erin Nelson, "Biobanking, Consent and Control: A Survey of Albertans on Key Research Ethics Issues" (2012) Biopreservation and Biobanking, 10:5, 433-438. (PR)
Timothy Caulfield and Celeste Condit, "Science and the Sources of Hype" (2012) 15 Public Health Genomics 209–217. (PR)
John C. Spence, Nicolas Holt, Christopher Sprysak, Nancy Spencer-Cavaliere and Timothy Caulfield, “Non-Refundable Tax Credits an Inequitable Policy Instrument for Promoting Physical Activity Among Canadian Children” (2012) 103 Canadian Journal of Public Health 175-177. (PR)
Timothy Caulfield, Amy Zarzeczny, et al., “Stem cell tourism and Canadian family physicians” (2012) 58 Canadian Family Physician 365-8. (PR)
Timothy Caulfield, Shawn HE Harmon and Yann Joly, “Open science versus commercialization: a modern research conflict?” (2012) 4 Genome Medicine 1-11. (PR)
Christopher Thomas Scott, Timothy Caulfield, Emily Borgelt & Judy Illes, “Personal medicine—the new banking crisis” (2012) 30 Nature Biotechnology 141-147. (PR)
Timothy Caulfield & Ubaka Ogbogu, “Stem cell research, scientific freedom and the commodification concern” (2012) 13 EMBO Reports 12-16. (PR)

Timothy Caulfield, “DTC Genetic Testing: Pendulum Swings and Policy Paradoxes” (2012) 81 Clinical Genetics 4-6. (PR)

Timothy Caulfield, “The Law, Unproven CAM and the Two-Hats Fallacy” (2012) 17 Focus on Alternative and Complementary Therapies 4-8. (PR)

Timothy Caulfield, “Commercialization Creep” (December 2012) Policy Options 20-23.


Timothy Caulfield, “Patents or Commercialization Pressure?: A (Speculative) Search for the Right Target” (2012) 22 Journal of Law, Information and Science 122-131. (PR)
Christen Rachul, Amy McGuire and Timothy Caulfield, "Public Perceptions and Biobanking: What Does the Research Really Say?" (2012) 6 Studies in Ethics, Law, and Technology 1-17. (PR)
Timothy Caulfield, “First Steps – Keeping stem cell tourists grounded” (November 2012) Policy Options 4-5.
Shawn Harmon, Timothy Caulfield and Yann Joly, “Commercialization versus Open Science: Making Sense of the Message(s) in the Bottle” (2012) 12 Medical Law International 3-10. (PR)
Blake Murdoch, Robyn Hyde-Lay and Timothy Caulfield, “An Examination of the Public Justifications for the Expansion of Canadian Naturopaths’ Scope of Practice” (2012) 19 Health Law Journal 215-236. (PR)
Amy Zarzeczny and Timothy Caulfield, “Legal liability and research ethics boards: The case of neuroimaging and incidental findings” (2012) 35 International Journal of Law and Psychiatry 137-144. (PR)

Timothy Caulfield, “Perspective: Should We Call It Fraud?” (2012) 42 Hastings Center Report (inside back cover). PubMed ID: 22616400.

Zubin  Master,  Nola  M.  Ries and Timothy Caulfield, “Balancing Efficiency and the Protection of Research Participants: Canadian Allergy/Asthma Researchers’ Perspectives on the Ethics Review of Multi-Site Health Research” (2011) 2(5) Journal of Clinical Research and Bioethics. (PR)

Timothy Caulfield and Amy McGuire, “Direct-to-Consumer Genetic Testing: Perceptions, Problems and Policy Responses” (2012) 63 Annual Review of Medicine 23-33. PubMed ID: 21888511. (PR)

Blake Murdoch, Christen Rachul and Timothy Caulfield, “Biotechnology and Science in Video Games: A Destructive Portrayal?” (2011) 20 Health Law Review 13-17. (PR)

Timothy Caulfield and Christen Rachul, “Supported by Science?: What Canadian Naturopaths Advertise to the Public” (2011) 7 Allergy, Asthma & Clinical Immunology 14. (PR)

Christen Rachul and Timothy Caulfield, “Food Allergy Policy and the Popular Press: Perspectives From Canadian Newspapers” (2011) Journal of Asthma and Allergy Educators 2:6, 282-287. (PR)

Christen M. Rachul, Nola M. Ries, and Timothy Caulfield “Canadian Newspaper Coverage of the A/H1N1 Vaccine Program” (2011) 102 Canadian J Public Health 200-3. (PR)

Timothy Caulfield and Christen Rachul, “Science Spin: iPS Cell Research in the News” (2011) 89 Clinical Pharmacology and Therapeutics 644-646. (PR)

Timothy Caulfield, “Direct-to-consumer testing: If consumers aren’t anxious, why are policymakers?” (2011) 130 Human Genetics 23-25. (PR)

Timothy Caulfield, “Reflection on the Gene Patent War: The Myriad Battle, Sputnik and Beyond” (2011) 57 Clinical Chemistry 977-79. (PR)

James Evans, Eric Meslin, Theresa Marteau, and Timothy Caulfield, “Deflating the Genomic Bubble” (2011) 331 Science 861-862. (PR)

Charles Auffray, Timothy Caulfield, Muin Khoury, James Lupski, Matthias Schwab, and Timothy Veenstra, “Genome Medicine: past, present and future” (2011) 3 Genome Medicine. (PR)

Timothy Caulfield, “The Biobanking Quandary: Getting and Withdrawing Consent (2011) 12 Harvard Health Policy Review 21-24. (PR)

Timothy Caulfield, “Predictive of Preposterous?: The Marking of DTC Genetic Testing” (2011) 10 Journal of Science Communication 1-6. (PR)

Timothy Caulfield, “Letter–That Personal Touch: Realistic Expectations for Personalized Medicine” (May-June 2011) Hasting Center Report 4.

Timothy Caulfield, Nola Ries, and Graham Barr, “Variation in Ethics Review of Multi-Site Research Initiatives” (2011) 2 Amsterdam Law Forum 85-100. (PR)

Amy McGuire, Barbara Evans, Timothy Caulfield, and Wylie Burke, “Regulating Direct-to-Consumer Personal Genome Testing” (2010) 330 Science 181-182. (PR)

Amy Zarzeczny, Christen Rachul, Matthew Nisbet, and Timothy Caulfield, “Stem Cell Clinics in the News” (2010) 28 Nature Biotechnology 1243-1246. (PR)

Christen Rachul, Colin Ouellette, and Timothy Caulfield, “Tracing the Use and Source of Racial Terminology in Representations of Genetic Research” (2010) 12 Genetics in Medicine 314-319. (PR)

Tania Bubela and Timothy Caulfield, “Role and Reality: Technology Transfer at Canadian Universities” (2010) 28 Trends in Biotechnology 447-51. (PR)

Timothy Caulfield and Amy Zarzeczny, “Popular Culture Representations of Science: Views from the Canadian Stem Cell Research Community” (2010) 6 Stem Cell Review and Reports 337-339. (PR)

John S. Gill, et al., Timothy Caulfield, “Policy Statement of Canadian Society of Transplantation and Canadian Society of Nephrology on Organ Trafficking and Transplant Tourism” (2010) Transplantation. (PR)

Timothy Caulfield, Nola Ries, Peter Ray, C. Shuman, and Brenda Wilson, “Direct-to-Consumer Genetic Testing: Good, Bad or Benign?” (2010) 77 Clinical Genetics 101-105. (PR)

Nola Ries, Christen Rachul, and Timothy Caulfield, “Newspaper reporting on legislative and policy interventions to address obesity: United States, Canada and the United Kingdom” (2010) Journal of Public Health Policy 1-18. PubMed ID: 21109764. (PR)

Yann Joly, Timothy Caulfield, Bartha M. Knoppers, Eef Harmsen, and Tomi Pastinen, “The Commercialization of Genomic Research in Canada” (2010) 6 Healthcare Policy 24-32. (PR)

Timothy Caulfield Christen Rachul, Amy Zarzeczny, and Henrik Walter, “Mapping The Coverage Of Neuroimaging Research” (2010) 7 SCRIPTed 421-428.

Timothy Caulfield, “Stem Cell Research and Economic Promises” (2010) 38 Journal of Law, Medicine and Ethics 303- 313. (PR)

Christen Rachul, Amy Zarzeczny, Tania Bubela, and Timothy Caulfield, “Stem Cell Research in the News: More than a Moral Status Debate” (2010) 7 ScriptED 311-323. (PR)

Timothy Caulfield and Bartha Knoppers, “Introduction: The Age of Personal Genomics” (2010) 13 Public Health Genomics 320-21. (PR)

Amy Zarzeczny and Timothy Caulfield, “Stem Cell Tourism and Doctors’ Duties to Minors – A View from Canada” (2010) 10 American Journal of Bioethics 3-15. (PR)

Nola Ries, Jane LaGrandeur, and Timothy Caulfield, “Handling Ethical, Legal and Social Issues in Birth Cohort Studies Involving Genetic Research: Responses from Studies in Six Countries” (2010) 11 BMC Medical Ethics. (PR)

Timothy Caulfield, Christen Rachul, and Amy Zarzeczny, “Commentary: ‘Neurohype’ and the Name Game: Who’s to Blame?” (2010) 1 AJOB Neuroscience 13-15. (PR)

Nola Ries, Robyn Hyde-Lay, and Timothy Caulfield, “Willingness to Pay for Genetic Testing: A Study of Attitudes in a Canadian Population” (2010) 13 Public Health Genomics 292-300. (PR)

Timothy Caulfield, Christopher Scott, Insoo Hyun, Robin Lovell-Badge, Kazuto Kato, and Amy Zarzeczny, “Stem cell research policy and iPS cells” (2010) 7(1) Nature Methods 28-33; published online December 21, 2009. (PR)

Amy Zarzeczny, Christopher Scott, Insoo Hyun, Jami Bennett, Jennifer Chandler, Sophie Chargé, Heather Heine, Rosario Isasi, Kazuto Kato, Robin Lovell-Badge, Kelly McNagny, Duanqing Pei, Janet Rossant, Azim Surani, Patrick L. Taylor, Ubaka Ogbogu, and Timothy Caulfield, “iPS Cells: Mapping the Policy Issues” (2009) 139(6) Cell 1032-1037. (PR)

Timothy Caulfield, Amy Zarzeczny, Jennifer McCormick, et al., “The Stem Cell Research Environment: A Patchwork of Patchworks” (2009) Stem Cell Reviews and Reports - doi:10.1038/stemcells.2009.61. (PR)

Amy Zarzeczny and Timothy Caulfield, “Emerging Ethical, Legal and Social Issues Associated with Stem Cell Research and the Current Role of the Moral Status of the Embryo” (2009) Stem Cell Reviews and Reports - doi: 10.1007/s12015-009-9062-4. (PR)

Timothy Caulfield, Amy Zarzeczny, Jennifer McCormick, et al., “International stem cell environments: a world of difference” (2009) Nature Reports Stem Cells - doi:10.1038/stemcells.2009.61. (PR)

Timothy Caulfield, “Nutrigenomics Patents and Commercialization: Old Wine in a New Bottle?” (2009) 13 OMICS: A Journal of Integrative Biology 63-67. (PR)

Tania Bubela, Matthew Nisbet, Rick Borchelt, Fern Brunger, Cristine Critchley, Edna Einsiedel, Gail Geller, Anil Gupta, Jürgen Hampel, Robyn Hyde-Lay, Eric W Jandciu1, S Ashley Jones, Pam Kolopack, Summer Lane, Tim Lougheed, Brigitte Nerlich, Ubaka Ogbogu, Kathleen O’Riordan, Colin Ouellette, Mike Spear, Stephen Strauss, Thushaanthini Thavaratnam, Lisa Willemse, and Timothy Caulfield, “Science communication reconsidered” (2009) 27 Nature Biotechnology 514-518. (PR)

C.J. Murdoch and Timothy Caulfield, “Commercialization, Patenting and Genomics: Researcher Perspectives” (2009) 1:22 Genome Medicine. (PR)

Peter Rugg-Gunn, Ubaka Ogbogu, Janet Rossant, and Timothy Caulfield, “The Challenge of Regulating Rapidly Changing Science: Stem Cell Legislation in Canada” (2009) 4 Cell Stem Cell 285-288. (PR)

Timothy Caulfield, Stephanie M Fullerton, Sarah E Ali-Khan, et al., “Race and Ancestry in Biomedical Research: Exploring the Challenges” (2009) 1:8 Genome Medicine. (PR)

Timothy Caulfield, “Human Gene Patents: Proof of Problems?” (2009-2010) 84 Chicago-Kent Law Review 133-145. (PR)

Timothy Caulfield and Jane Kaye, “Broad Consent in Biobanking: Reflections on Seemingly Insurmountable Dilemmas” (2009) 10 Medical Law International 85-100. (PR)

Timothy Caulfield, Victor Alfonso, and Jacob Shelley, “Deterministic?: Newspaper Representations of Obesity and Genetics” (2009) 1 The Open Obesity Journal. (PR)

Timothy Caulfield, “Direct-to-Consumer Genetics and Health Policy: A Worst-Case Scenario?” (2009) 9 American Journal of Bioethics 48-50. (PR)

Alethea Adair, Robyn Hyde-Lay, Edna Einsiedel, and Timothy Caulfield, “Technology Assessment and Resource Allocation for Predictive Genetic Testing: A Study of the Perspectives of Canadian Health Care Providers” (2009) 10 BMC Medical Ethics 6. (PR)

Timothy Caulfield and Charles Weijer, “Minimal Risk and Large-Scale Biobank and Cohort Research” (2009) 17 Health Law Review 53-58. (PR)

Timothy Caulfield, “Defining ‘Race’ as the Defining Problem” (2009) 45 Houston Law Review 1475-1482. (PR)

Darren Lau, Ubaka Ogbogu, Benjamin Taylor, Tania Stafinski, Devidas Menon, and Timothy Caulfield, “Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of StemCell Medicine” (2008) 3 Cell Stem Cell 591-594. (PR)

Timothy Caulfield, Ubaka Ogbogu, Charles Murdoch, and Edna Einsiedel, “Patent, Commercialization and the Canadian Stem Cell Community” (2008) 3 Regenerative Medicine 483-496. (PR)

Timothy Caulfield, Tania Bubela, and C.J. Murdoch, “Myriad and the Mass Media: The Covering of a Gene Patent Controversy” (2008) 9 Genetics in Medicine 850-855. (PR)

Timothy Caulfield, Amy McGuire, Mildred Cho, et al, “Research Ethics Recommendations for Whole Genome Research: Consensus Statement” (2008) 6 PLoS Biology 1-6. (PR)

Amy McGuire, Timothy Caulfield, and Mildred Cho, “Research Ethics and the Challenges of Whole-Genome Research” (2008) 9 Nature Reviews Genetics 152-156. (PR)

Erin Nelson, Ubaka Ogbogu, and Timothy Caulfield, “An Investigation of Embryo Donation, Informed Consent and Research Oversight in Canadian Human Embryonic Stem Cell Research” (2008) 29 Journal of Obstetrics and Gynaecology Canada 997-1002. (PR)

Timothy Caulfield, Jacob Shelley, Victor Alfonso, and Tania Bubela, “Nutrigenomics and the Promise of Prevention: Representations and Realities” (Special Issue 2008) Health Law Journal 41-66. (PR)

Simrat Harry and Timothy Caulfield, “BiDil, Clinical Trials and the Popular Press: An Exploration of Newspaper Coverage” (2008) 17 Health Law Review 46-50.

Tania Bubela, Heather Boon, and Timothy Caulfield, “Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals” (2008) 6 BMC Medicine. (PR)

Timothy Caulfield and Simrat Harry, “Popular Representations of Race: The News Coverage of BiDil” (2008) 36 Journal of Law Medicine and Ethics 485-490. (PR)

Timothy Caulfield and Ubaka Ogbogu, “Biomedical research and the commercialization agenda: A review of main considerations for neuroscience” (2008) 15 Accountability in Research 303-320. (PR)

Beth Potter, D. Avard, I.D. Graham, V.A. Entwistle, T. Caulfield, P. Chakaborty, C. Kennedy, M. McGuire, G. Griener, M. Montgomery, G.A. Wells, and B.J. Wilson, “Guidance for Considering Ethical, Legal, and Social Issue in Health Technology Assessment: Application to Genetics Screening” (2008) 24 International Journal of Technology Assessment in Health Care 412-422. (PR)

Ubaka Ogbogu, Timothy Caulfield, and Shane Green, “From Human Embryos to Interspecies Creations: Ethical and Legal Uncertainties Surrounding the Creation of Cytoplasmic Hybrids for Research” (2008) 9 Medical Law International 227-244. (PR)

Julian Little, Beth Potter, Judith Allanson, Timothy Caulfield, and Brenda Wilson, “Canada: Public Health Genomics” (2008) 12 Public Health Genomics 112-120. (PR)

Timothy Caulfield, “Nutrigenomics, Popular Representations and the Reification of ‘Race’” (2008) 16:3 Health Law Review 50-57.

Timothy Caulfield, Tania Bubela, and C.J. Murdoch, “Myriad and the Mass Media: The Covering of a Gene Patent Controversy” (2008) 9 Genetics in Medicine 850-855. (PR)

Timothy Caulfield, et al., “Stem Cell Research Ethics: Consensus Statement on Emerging Issues” (2007) 29 Journal of Obstetrics and Gynaecology Canada 843-848. (PR)

Amy McGuire, Mildred Cho, Sean McGuire, and Timothy Caulfield, “The Future of Personal Genomics” (2007) 317 Science 1687. (PR)

Timothy Caulfield, Ubaka Ogbogu, and Rosario Isasi, “Informed consent in embryonic stem cell research: Are we following basic principles?” (2007) 176 Canadian Medical Association Journal 1722-1725. (PR)

Timothy Caulfield, “Obesity, Legal Duties and the Family Physician” (2007) 53 Canadian Family Physician 1129-1130. (PR)

Timothy Caulfield, “Biobanks and Blanket Consent: The Proper Place of the Public Perception and Public Good Rationales” (2007) 18 King’s Law Journal 209-226. (PR)

Timothy Caulfield, “Profit and the Production of the Knowledge: The Impact of Industry on Representations of Research Results” (2007) 8 Harvard Health Policy Review 68-77. (PR)

Timothy Caulfield, Russ Brown, and Eric Meslin, “Challenging a Well Established Consent Norm?: One Time Consent for Biobank Research” (2007) 4 Journal of International Biotechnology Law 69-74. (PR)

Tania Bubela, Timothy Caulfield, and Megan Koper, “Media portrayal of herbal remedy versus pharmaceutical clinical trials: Impacts on decision makers” (2007) 26 Medicine and Law Journal 363-373. (PR)

Timothy Caulfield and Tania Bubela, “Why a Criminal Ban?: Analyzing the Arguments Against Somatic Cell Nuclear Transfer in the Canadian Parliamentary Debate” (2007) 7 American Journal of Bioethics 51-71. (PR)

Timothy Caulfield, Edna Einsiedel, Jon Merz, and Dianne Nicol, “Trust, Patents, and Public Perceptions: The Governance of Controversial Biotechnology Research” (2006) 24 Nature Biotechnology 1352-54. (PR)

Timothy Caulfield, “Introduction: Genetic Diversity and Science Communication” (2006) 70 Clinical Genetics 424-426. (PR)

Timothy Caulfield, Bob Cook-Deegan, Scott Kieff, and John Walsh, “Evidence and Anecdotes: An Analysis of Human Gene Patenting Controversies” (2006) 24 Nature Biotechnology 1091-1094. (PR)

Timothy Caulfield and Barbara von Tigerstrom, “Gene Patents, Health Care Policy and Licensing Schemes” (2006) 24 Trends in Biotechnology 251-254. (PR)

Nola Ries and Timothy Caulfield, “First Pharmacogenomics, Next Nutrigenomics: Genohype or Genohealthy?” (2006) 46 Jurimetrics 281-308. (PR)

Timothy Caulfield, “Stem Cell Patents and Social Controversy: A Speculative View From Canada” (2006) 7 Medical Law International 219-232. (PR)

Suzanne DeBow, Tania Bubela, and Timothy Caulfield, “Stem Cells, Politics and the Progress Paradigm” (2006) 15 Health Law Review 50-52.

Tania Bubela, Timothy Caulfield, and Heather Boon, “Trends in Evidence Based Medicine for Herbal Remedies and Media Coverage” (2006) 15 Health Law Review 3-8.

Megan Koper, Tania Bubela, Timothy Caulfield, and Heather Boon, “Media Portrayals of Conflicts of Interest in Herbal Remedy Clinical Trials” (2006) 15 Health Law Review 9-11.

Timothy Caulfield, “Chaoulli v. Quebec (Attorney General): The Supreme Court of Canada Deals a Blow to Publicly Funded Health Care” (2006) Health Law Perspectives https://www.law.uh.edu/healthlaw/perspectives/September2005/(TC)ChaoulliComment.pdf

Timothy Caulfield and Roger Brownsword, “Human Dignity: What Does It Mean in the Biotechnology Era?” (2005) 7 Nature Reviews Genetics 72-76. (PR)

Timothy Caulfield and Audrey Chapman, “Human Dignity as a Criterion for Science Policy” (2005) 2 PLoS Medicine 101-103. (PR)

Nola M. Ries and Timothy Caulfield, “Legal Foundations for a National Public Health Agency in Canada” (2005) 96 Canadian Journal of Public Health 281. (PR)

Timothy Caulfield and Suzanne Debow, “A systematic review of how homeopathy is represented in conventional and CAM peer reviewed journals” (2005) 5 BMC Complementary and Alternative Medicine 12-16. (PR)

Timothy Caulfield, “The Commercialization of Medical and Scientific Reporting” (2005) 1 PLoS Medicine 178-179. (PR)

Yann Joly, Richard Gold, and Timothy Caulfield, “Genetic Research Tools, the Research Exception and Open Science” (2005) 3 GeneEdit http://www.humgen.umontreal.ca/int/GE/en/2005-2.pdf

Timothy Caulfield, “Policy Conflicts: Gene Patents and Health Care in Canada” (2005) 8 Community Genetics 223-227. (PR)

Timothy Caulfield, “Popular Media, Biotechnology and the ‘Cycle of Hype’” (2005) 5 Journal of Health Law and Policy 213-233. (PR)

Timothy Caulfield, “Legal and Ethical Issues Associated with Patient Recruitment in Clinical Trials: The Case of Competitive Enrolment” (2005) 13 Health Law Review 58-61.

Timothy Caulfield, “An Independent Voice?: Conflicts of Interest and Research on Ethical, Legal and Social Issues” (2005) 13 Health Law Review 114-116.

Timothy Caulfield, Lori Knowles, and Eric Meslin, “Law and Policy in the Era of Reproductive Genetics” (2005) 30 Journal of Medical Ethics 414-417. (PR)

Steven Kleinman, Timothy Caulfield, Penny Chan, et al., “Toward an Understanding of Transfusion-Related Acute Lung Injury: A Statement of a Consensus Panel” (2004) 44 Transfusion 1774-1789. (PR)

Timothy Caulfield, “Scientific Freedom and Research Cloning: Can a Ban Be Justified?” (2004) 364 The Lancet 124-127. (PR)

Timothy Caulfield, “Biotechnology and the Popular Press: Hype and the Selling of Science” (2004) 22 Trends in Biotechnology 337-339. (PR)

Tania Bubela and Timothy Caulfield, “Do the Print Media ‘Hype’ Genetic Research?: A Comparison of Newspaper Stories and Peer-Reviewed Research Papers” (2004) 170 Canadian Medical Association Journal 1399-1407. (PR)

Shaun Pattinson and Timothy Caulfield, “Variations and Voids: The Regulation of Human Cloning Around the World” (2004) 5 BMC Medical Ethics 9. (PR)

Timothy Caulfield and Lorraine Sheremeta, “Biotechnology Patents and Embryonic Stem Cell Research: Emerging Issues (Part II)” (2004) 1 Journal of International Biotechnology Law 142-145. (PR)

Timothy Caulfield and Nola Ries, “Consent, Privacy and Confidentiality in Longitudinal, Population Health Research: Canadian Legal Context” (2004) Health Law Journal, Supplement 1-65. (PR)

Timothy Caulfield and Lorraine Sheremeta, “Biotechnology Patents and Embryonic Stem Cell Research: Emerging issues (Part I)” (2004) 1 Journal of International Biotechnology Law 98-104. (PR)

Timothy Caulfield “Nanotechnology: Facts and Fictions” (2004) 12 Health Law Review 3-4.

Timothy Caulfield and Tania Bubela, “Media Representations of Genetic Discoveries: Hype in the Headlines?” (2004) 12 Health Law Review 53-61.

Timothy Caulfield, Trudo Lemmens, Douglas Kinsella, and Michael McDonald, “Research Ethics and the Role of the Professional Bodies: A View from Canada” (2004) 32 The Journal of Law, Medicine and Ethics 365-368. (PR)

Barbara Billingsley and Timothy Caulfield, “The Regulation of Science and the Charter of Rights: Would a Ban on Non-Reproductive Human Cloning Unjustifiably Violate Freedom of Expression?” (2004) 29 Queen’s Law Journal 647-679. (PR)

Linda Pilarski, Michael Mehta, Timothy Caulfield, et al., “Microsystems and Nanoscience for Biomedical Applications: A View to the Future” (2004) 24 Bulletin of Science, Technology and Society 40-45.

Timothy Caulfield, “Gene Patents, Human Clones and Biotechnology Policy: The Challenge Created by Globalization” (2004) 3 Alberta Law Review 713-24. (PR)

Timothy Caulfield, Lorraine Sheremeta, and Abdallah Daar, “Somatic Cell Nuclear Transfer – How Science Outpaces the Law” (Correspondence) (2003) 21 Nature Biotechnology 969-970. (PR)

Timothy Caulfield, “From Human Genes to Stem Cells: New Challenges for Patent Law?” (2003) 21 Trends in Biotechnology 100-103. (PR)

Timothy Caulfield, “The Regulation of Embryonic Stem Cell Research: A Few Observations on the International Scene” (2003) Health Law Journal, Special Edition 87-95. (PR)

Timothy Caulfield, “The Commercialization of Human Genetics: Future Policy Concerns” (2003) 15 Journal of History of Medicine (Medicina nei Secoli) 55-70. (PR)

Timothy Caulfield, “Sustainability and the Balancing of the Health Care and Innovation Agendas: the Commercialization of Genetic Research” (2003) 66 Saskatchewan Law Review 629-645. (PR)

Timothy Caulfield, “Human Cloning Laws, Human Dignity and the Poverty of the Policy Making Dialogue” (2003) 4 BMC Medical Ethics 3-10. (PR)

Timothy Caulfield, Ross Upshur, and Abdallah Daar, “DNA Databanks and Consent: A Suggested Policy Option Involving An Authorization Model” (2003) 4 BMC Medical Ethics 1. (PR)

Timothy Caulfield, Bartha Maria Knoppers, Richard Gold, et al., “Genetic Technologies, Health Care Policy and the Patent Bargain” (2002) 63 Clinical Genetics 15-18. (PR)

Richard Gold, Timothy Caulfield, and Peter Ray, “Gene Patents and the Standard of Care” (2002) 167 Canadian Medical Association Journal 256-57. (PR)

Richard Gold and Timothy Caulfield, “The ‘Moral Tollbooth’: A Method That Makes Use of the Patent System To Address Ethical Concerns in Biotechnology” (2002) 359 The Lancet 2268-70. (PR)

Timothy Caulfield, “Bill C-13: The Assisted Human Reproduction Act: Examining the Arguments Against a Regulatory Approach” (2002) 11 Health Law Review 20-25.

Timothy Caulfield and Tim Outerbridge, “DNA Databanks, Public Opinion, and the Law” (2002) 25 Clinical and Investigative Medicine 252-56. (PR)

Timothy Caulfield, “Politics, Prohibitions and the Lost Public Perspective: A Comment on Bill C-56: The Assisted Human Reproduction Act” (2002) 40 Alberta Law Review 451-463. (PR)

Timothy Caulfield and Glenn Griener, “Conflicts of Interest in Clinical Research: Addressing the Issue of Physician Remuneration” (2002) 30 The Journal of Law, Medicine and Ethics 305-308. (PR)

Timothy Caulfield, “Commentary: Cloning and Genetic Determinism: A Call for Consistency” (2001) 19 Nature Biotechnology 403. (PR)

Timothy Caulfield, “Liability in the Genetic Era: Wrongful Birth and Wrongful Life Lawsuits” (2001) 23 Journal of the Society of Obstetricians and Gynaecologists of Canada 143-147. (PR)

Timothy Caulfield and Colin Feasby, “Potions, Promises and Paradoxes: Complementary and Alternative Medicine and Malpractice Law in Canada” (2001) 9 Health Law Journal 183-204. (PR)

Timothy Caulfield, “Globalization, Conflicts of Interest and Clinical Research: An Overview of Trends and Issues” (2001) 8 Widener Law Symposium Journal 31-45. (PR)

Timothy Caulfield and Kerry Siminoski, “Physician Liability and Drug Formulary Restrictions” (2001) 166 Canadian Medical Association Journal 458-60. (PR)

Timothy Caulfield and Dorothy Wertz, “Creating Needs?: A Review of Survey Data and Concerns Relevant to the Commercialization of Genetic Testing” (2001) 4 Community Genetics 68-76. (PR)

Timothy Caulfield, “Clones, Controversy and Criminal Law: A Comment on the Proposal for Legislation Governing Assisted Human Reproduction” (2001) 39 Alberta Law Review 335-346. (PR)

Timothy Caulfield, “The Informed Gatekeeper?: A Commentary on Genetic Tests, Marketing Pressure and the Role of Primary Care Physicians” (2001) 9 Health Law Review 14-18.

Timothy Caulfield and Gerald Robertson, “Xenotransplantation: Consent, Public Health and Charter Issues” (2001) 5 Medical Law International 81-99. (PR)

Timothy Caulfield, Michael Burgess, Bryn Williams-Jones, et al., “Providing Genetic Testing Through the Private Sector: A View From Canada” (2001) 2 ISUMA: Canadian Journal of Policy Research 72-81. (PR)

Timothy Caulfield, Richard Gold, and Mildred Cho, “Patenting Human Genetic Material: Refocusing the Debate” (2000) 1 Nature Reviews Genetics 227-231. (PR)

Timothy Caulfield and Richard Gold, “Genetic Testing, Ethical Concerns and the Role of Patent Law” (2000) 57 Clinical Genetics 370-375. (PR)

Timothy Caulfield, “Genetic Testing, Liability and Regulatory Policy: The Canadian Situation” (Fall 2000) 41 Jurimetrics J. 7-21. (PR)

Barbara von Tigerstrom, Mylene Deschenes, Bartha Maria Knoppers, and Timothy Caulfield, “Legal Regulation of Cancer Surveillance: Canadian and International Perspectives” (2000) 8 Health Law Journal 1-94. (PR)

Timothy Caulfield, “Canadian Family Law and the Genetic Revolution: A Survey of Cases Involving Paternity Testing” (2000) 26 Queen’s Law Journal 67-100. (PR)

Timothy Caulfield and Richard Gold, “Whistling in the Wind: Reframing the Genetic Patent Debate” (2000) 15 Forum for Applied Research and Public Policy 75-79. (PR)

Timothy Caulfield, “Underwhelmed: Hyperbole, Regulatory Policy and the Genetic Revolution” (2000) 45 McGill Law Journal 437-460. (PR)

Timothy Caulfield, “Introduction: Genetics and the Law” (2000) 45 McGill Law Journal 343-45.

Timothy Caulfield, Colleen Flood, and Barbara von Tigerstrom, “Comment: Bill 11, Health Care Protection Act” (2000) 9 Health Law Review 22-25.

Timothy Caulfield, “Gene Testing in the Biotech Century: Are Physicians Ready?” (1999) 161 Canadian Medical Association Journal 1122-24. (PR)

Timothy Caulfield and Marie Hirtle, “Regulating the Genetic Revolution” (1999) 5 Molecular Medicine Today 198-200. (PR)

P. Florencio and T. Caulfield, “Xenotransplantation and Public Health: Identifying the Legal Issues” (1999) 90 Canadian Journal Public Health 282-84. (PR)

Timothy Caulfield, “The Law, Adolescents, and the APOE4 Genotype: A View from Canada” (1999) 3 Genetic Testing 107-113. (PR)

Timothy Caulfield and Gerald Robertson, “Cost Containment Mechanisms in Health Care: A Review of Private Law Issues” (1999) 27 Manitoba Law Journal 1-16. (PR)

Timothy Caulfield, “The Commercialization of Human Genetics: a Discussion of Issues Relevant to Canadian Consumers” (1999) 21 Journal of Consumer Policy 483-526; also published as a book chapter in Biotechnology and the Consumer (Kluwer Academic) 125-167. (PR)

Timothy Caulfield, “Health Law Issues in Canada Today: Emerging Genetic Policies” (1999) 2 Journal of the Centre for International Studies 103-111. (PR)

Timothy Caulfield, “The Commercialization of Human Genetics: Profits and Problems” (1998) 4 Molecular Medicine Today 148-150. (PR)

The Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics and Society, “Genetic Testing and Alzheimer Disease: Has the Time Come?” (1998) 4 Nature Medicine 757-759. (PR)

Timothy Caulfield and Bartha Maria Knoppers, “Genetic Testing, Legal Capacity and Adolescents” (1998) 6 Health Law Journal 115-129. (PR)

Erin Nelson and Timothy Caulfield, “You Can’t Get There From Here: A Case Comment on Arndt v. Smith” (1998) 32 University of British Columbia Law Review 353-64. (PR)

Timothy Caulfield and Erin Nelson, “Winnipeg Child and Family Services v. D.F.G.: A Commentary on the Law, Reproductive Autonomy and the Allure of Technopolicy” (1998) 36 Alberta Law Review 799-809. (PR)

Timothy Caulfield, “Attitudes Regarding the Notification of Individuals Exposed to CJD Associated Blood Products: A Survey of Albertans” (1998) 6 Health Law Review 20-23.

Timothy Caulfield, “Testing Adolescents for the Alzheimer Gene: Tensions in Law and Policy” (1998) 25 Manitoba Law Journal 31-47. (PR)

Timothy Caulfield, et al. “Recontacting Individuals Exposed to CJD-Associated Blood Products: Integrating Science, Legal Duties and Ethical Mandates” (1997) 157 Canadian Medical Association Journal 1389-1392. (PR)

Timothy Caulfield and Erin Nelson, “Health Legislation Trends in Canada” in the World Health Organization, Health Legislation in the English-Speaking Region: The Last Four Years: Technical Report Series No. 63 (Washington D.C: Pan American Health Organization, 1997).

Timothy Caulfield, “Health Reform, the Physician-Patient Relationship and Legal Duties in Canada” (1997) 43 Canadian Family Physician 2093-95. (PR)

Timothy Caulfield, Marie Hirtle, and Sonia LeBris, “NRTs: Is Criminalization the Solution for Canada?” (1997) 18 Health Law in Canada 3-14.

Douglas M. Sawyer and Timothy Caulfield, “Creutzfeldt-Jakob Disease and Blood Transfusion” (1997) 6 Health Law Review 12-17.

Timothy Caulfield, “Wishful Thinking: Defining Medically Necessary in Canada” (1996) 4 Health Law Journal 63-85. (PR)

Timothy Caulfield and Gerald Robertson, “Eugenic Policies in Alberta: From the Systematic to the Systemic?” (1996) 35 Alberta Law Review 59-79. (PR)

Timothy Caulfield, “Case Comment: ter Neuzen v. Korn and the Standard of Care: A Call for Caution” (1996) 34 Alberta Law Review 986-992. (PR)

Timothy Caulfield, “Paternity Testing in the Genetic Era” (1996) 17 Health Law in Canada 19-26.

Timothy Caulfield, “The Practice of Human Genetics: Emerging Areas of Consensus” (1995) 3 Health Law Journal 307-20. (PR)

Timothy Caulfield, “The Allocation of Genetic Services: Economics, Expectations, Ethics and the Law” (1995) 3 Health Law Journal 213-34. (PR)

Timothy Caulfield, “Practically Confidential: The Physician’s Duty” (1995) 41 Canadian Family Physician 2025-27. (PR)

Timothy Caulfield and Diana Ginn, “The High Price of Full Disclosure: Informed Consent and Cost Containment in Health Care” (1994) 22 Manitoba Law Journal 328-44. (PR)

Timothy Caulfield, “Health Care Reform: Can Tort Law Meet the Challenge?” (1994) 32 Alberta Law Review 685-721. (PR)

Timothy Caulfield, “Suing Hospitals, Health Authorities and the Government for Health Care Allocation Decisions” (1994) (Paper prepared for the Health Law Section of the Canadian Bar Association, Northern Alberta)

Timothy Caulfield, “Patient Choice and Privatization” (1994) 6 The Bioethics Bulletin 4-6.

Robert Elgie, Timothy Caulfield, and Michael Christie, “Medical Injuries and Malpractice: Is it Time for No Fault?” (1993) 1 Health Law Journal 97-117. (PR)
Book Chapters

Timothy Caulfield, “Genetic Research and Representations of Race” in John Stone, Rutledge M. Dennis, et al., eds. The Wiley Blackwell Encyclopedia of Race, Ethnicity and Nationalism (March 2016, Wiley-Blackwell) pp.


Timothy Caulfield, “Risk, Research and Your Tissue” in Christian Berco, Sean Caulfield and Isabelle Van Grimde, eds. The Body In Question(s) (Department of Art and Design, 2014) pp. 150-153.
Timothy Caulfield, “The Paradoxes of Pop Science” in Sean Caulfield, ed. Reflections on Perceptions of Promise: Biotechnology, Society and Art (Department of Art and Design, 2013) pp. 6-8.
Timothy Caulfield, “Genetics and Public Health: Legal, Ethical and Policy Challenges” in Nola Ries, Tracey Baily and Timothy Caulfield eds., Public Health Law and Policy in Canada, 3rd ed. (LexisNexis Canada, 2013) pp. 665-687.
Amy Zarzeczny, Christen Rachul and Timothy Caulfield, “Stem Cell Tourism” in Anthony Atala, ed., Progenitor and Stem Cell Technologies and Therapies (Philadelphia: Woodhead Publishing, 2012) pp 206-233.

Ciara Toole, Amy Zarzeczny and Timothy Caulfield, “Research Ethics Challenges in Neuroimaging Research: A Canadian Perspective” in Tade Mathias Springer, ed., International Neurolaw: A Comparative Analysis (Springer, 2012) pp. 89-102.

Timothy Caulfield, “Public Representations of Genetics: Reifying Race?” in Louis Maheu and Roderick MacDonald, eds. Challenging Determinism: New Perspectives on the Gene in Its Multiple (McGill-Queen’s University Press, 2011) pp. 158-181.

Amy Zarzeczny and Timothy Caulfield, “Public Representations of Neurogenetics”, in J. Illes and B.J. Sahakian eds., Oxford Handbook of Neuroethics (in press, June 2011).

Timothy Caulfield, “Stem Cell Research and Economic Promises” in Robert Kouri and Catherine Regis, eds., Grand Challenges in Health Law and Policy (Quebec: Yvon Blais, 2010) pp. 81-105.

Ubaka Ogbogu and Timothy Caulfield, “Human Dignity and Biotechnology Policy” in Paul Atkinson, Peter Glasner and Margaret Lock, eds., Handbook of Genetics and Society: Mapping the New Genomic Era (New York: Routledge, 2009) pp. 448-461.

Timothy Caulfield, “Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance?” in David Castle, ed., The Role of Intellectual Property Rights in Biotechnology Innovation (Edward Elgar Publishing, 2009) pp. 357-368.

Timothy Caulfield, Jacob Shelley, Tania Bubela, and Leia Minaker, “Framing Nutrigenomics for Individual and Public Health: Public Representations of an Emerging Field” in David Castle and Nola Ries eds., Nutrition and Genomics (Academic Press, San Diego, 2009) pp. 223-245.

Timothy Caulfield, “‘Looking Forward...’ Policy Papers Introduction” in Commission of Inquiry on Hormone Receptor Testing: Volume 2 (Government of Newfoundland and Labrador, 2009) pp. 1-4.

Tania Bubela and Timothy Caulfield, “When Human Dignity is Not Enough: Embryonic Stem Cell Research and Human Cloning in Canada” in Einsiedel EF, ed., Emerging Technologies: Hindsight and foresight (Vancouver: UBC Press, 2009) pp. 160-182.

Timothy Caulfield and Yann Joly, “Human Gene Patents and Genetic Testing; Chapter 36” in G. Patrinos and W. Ansorge, eds., Molecular Diagnostics, 2nd ed., (London: Elsevier, 2009) pp. 527-536.

Timothy Caulfield, “Living Organ Donation: Consent Challenges” in Nirmala Khadpekar ed., Ethics in Organ Transplantation: Perspectives and Challenges (The Icfai University Press, 2008) pp. 91-111.

Jocelyn Downie, Timothy Caulfield, and Colleen Flood, eds., Canadian Health Law and Policy, 3rd ed. (LexisNexis Canada, 2007) pp. 603.

Ian Kerr and Timothy Caulfield, “Emerging Health Technologies” in Jocelyn Downie, Timothy Caulfield, and Colleen Flood, eds., Canadian Health Law and Policy, 3rd ed. (LexisNexis Canada, 2007) pp. 509-538.

Timothy Caulfield and Tania Bubela, “The Popular Media, Public Perceptions and Biotechnology Policy” in Stranger, M., ed., Human Biotechnology and Public Trust: Trends, Perceptions and Regulation, Hobart: Centre for Law and Genetics, 2007) pp. 88-102.

Timothy Caulfield, “Revisiting Core Principles: Autonomy, Consent and the Biobanking Challenge” in Jocelyn Downie and Elaine Gibson, eds., Health Law at the Supreme Court of Canada (Toronto: Irwin Law Inc., 2007) pp. 169-188.

Timothy Caulfield and Tania Bubela, “Popular Representations of Science, Research and Technology” in Nola Ries and Jacob Shelley, eds., Food, Health and Biotechnology: Consumer and Social Issues in Canada’s New Food and Health Products Industries (Advanced Food and Materials Network, 2007) pp. 24-28.

Timothy Caulfield and Nola Ries, “Public Opinion, Consent and Population Genetic Biobanks” in Bartha Knoppers, ed., Genomics and Public Health: Legal and Socio-Ethical Perspectives (Boston: Martinus Nijhoff Publisheres, 2007) pp. 183-195.

Timothy Caulfield, “Stem Cells, Clones, Consensus and the Law” in Lori Knowles and Gregory E. Kaebnick, eds., Shaping Our Future: Law, Policy, and Ethics in an Era of Reproductive Genetics (Johns Hopkins University Press, 2007) pp. 105-123.

Timothy Caulfield, “The Media, Marketing and Genetic Services” in Colleen Flood, ed., Just Medicare: What’s In, What’s Out, How We Decide (University of Toronto Press, 2006) pp. 379-395.

Timothy Caulfield, Lorraine Sheremeta, E. Richard Gold, Jon Merz, and David Castle, “Informing genomic patent policy” in N.F. Sharpe and R.F. Carter, eds. Genetic Testing: Care, Consent and Liability (New Jersey: John Wiley and Sons, 2006) pp. 328-339.

Timothy Caulfield and Nola Ries, “Politics and Paradoxes: Chaoulli and the Alberta Reaction” in Colleen Flood, Lorne Sossin, and Kent Roach, eds., Access to Care, Access to Justice: The Legal Debate Over Private Health Insurance in Canada (University of Toronto Press, 2005) pp. 413-428.

Tania Bubela and Timothy Caulfield, “Media Representations of Genetic Research” in E. Einsiedel and F. Timmermans, eds., Crossing Over: Genomics in the Public Arena (University of Calgary Press, 2005) pp. 117-130.

Timothy Caulfield, “Human Cloning and Stem Cell Policies: Balancing Public Opinion and Moral Perspectives” in A. Eisen and G. Laderman, eds., Science, Religion, and Society: History, Culture, and Controversy, (ME Sharpe; New York)

Timothy Caulfield and Barb von Tigerstrom, “Globalization and Biotechnology Policy: The Challenges Created by Gene Patents and Cloning Technologies” in Belinda Bennett and George F. Tomossy, eds., Globalization and Health: Challenges for Health Law and Bioethics, (Springer: International Library of Ethics, Law and the New Medicine, 2005) pp. 129-149.

Timothy Caulfield, “Human Gene Patents and Genetic Testing; Chapter 30” in G. Patrinos and W. Ansorge, eds., Molecular Diagnostics (London: Elsevier, 2005) pp. 391-397.

Timothy Caulfield, “Perceptions of Risk and Human Genetic Databases: Consent and Confidentiality Policies” in G. Arnason, Salvor Nordel, and V. Arnason, eds., Blood and Data: Ethical, Legal and Social Aspects of Human Genetics Databases (Reykjavik: University of Iceland Press and Centre for Ethics, 2004) pp. 283-89.

Lorraine Sheremeta, Richard Gold, and Timothy Caulfield, “Harmonizing Commercialization and Gene Patent Policy with other Social Goals” in B. M. Knoppers, ed., Population and Genetics: Legal and Socio-Ethical Perspectives (The Netherlands: Koninklijke Brill, 2003) pp. 423-452.

Timothy Caulfield, “Commercialization of Human Genetic Research” in Nature Encyclopedia of the Human Genome (London: Nature Publishing Group, 2003).

Timothy Caulfield, “Tissue Banking, Patient Rights, and Confidentiality: Tensions in Law and Policy,”14th World Congress on Medical Law: Book of Proceedings (World Associated for Medical Law, 2002) pp. 22-30.

Timothy Caulfield, “Regulating the Genetic Revolution: What is and isn’t happening in Canada” in Marcia Munoz de Alba Medrano, eds., Reflexiones en torno al derecho genomico (Universidad Nacional Autonoma de Mexico, 2002) pp. 83-91.

Timothy Caulfield, “Malpractice in the Age of Health Care Reform” in Barbara von Tigerstrom and Timothy Caulfield, eds., Meeting the Challenge: Health Care Reform and the Law (University of Alberta Press, 2002) 288 pp.

Expert Panel (Co-author), The Royal Society of Canada Elements of Precaution: Recommendations for the Regulation of Food Biotechnology in Canada (Royal Society of Canada, 2001) 245 pp.

Timothy Caulfield, “Genetics and the Law” in Canadian Health Law Practice Manual (Toronto: Butterworths, 2000) pp.11.1-11.22.

Timothy Caulfield, “Tensions in Ethics Policy: The Consumer vs. The Citizen” in M. Sommerville, ed., Do We Care?: Renewing Canada’s Commitment to Health (Montreal: McGill-Queens University Press, 1999) pp. 118-21.

Timothy Caulfield, “Regulating the Commercialization of Human Genetics: Can We Address the Big Concerns?” in A. Thompson and R. Chadwick, Genetic Information (New York: Kluwer Academic/Plenum Publishing, 1999) pp. 149-161.

Timothy Caulfield and Colin Feasby, “The Commercialization of Human Genetics in Canada: An Overview of Policy and Legal Issues” in Socio-Ethical Issues in Human Genetics (Montreal: Yvon Blais, 1998) pp. 343-401.

Timothy Caulfield, “The Status of Human Genetic Material” in Bartha Maria Knoppers, Claude Laberge, and Maria Hirtle, eds., Human DNA: Law and Policy: International and Comparative Perspectives (The Hague: Kluwer Law International, 1997) pp. 63-67.

Timothy Caulfield, Kathy Cherniawsky, and Erin Nelson, “Patent Law and Human DNA: Current Practices and Future Problems” in Legal Rights and Human Genetic Material (Toronto: Emond Montgomery, 1996) pp. 117-148.

Timothy Caulfield, P. James, G. Marriott, et al., “Medical Law, Supplement 8, Canada” in H. Nys, ed., International Encyclopedia of Laws (The Hague: Kluwer Law International, 1996), 146 pp.

Timothy Caulfield, “Oregon’s Health Care Plan: An Answer for Canada?” in Michael Stingl and Donna Wilson, eds., Efficiency v. Equality: Health Reform in Canada (Fernwood, 1996) pp. 27-35.



Download 477.43 Kb.

Share with your friends:
  1   2   3   4   5   6




The database is protected by copyright ©ininet.org 2023
send message

    Main page